Last updated on February 2017

Dose-escalation Trial of the Safety Pharmacokinetics and Pharmacodynamics of Iron Isomaltoside (Monofer )

Brief description of study

The trial is an open-label, 4 cohorts, sequential, dose-escalating, single dose trial.

Detailed Study Description

IDA is highly prevalent in subjects with cancer and gastrointestinal diseases such as inflammatory bowel diseases, menstruating or pregnant women, and subjects who have undergone bariatric procedure. IDA can have a substantial medical and quality of life (QoL) burden on the subjects, and treatment of these subjects includes controlling the bleeding and replenishing lost iron.

Clinical Study Identifier: NCT03013439

Find a site near you

Start Over


Tokyo, Japan
  Connect »